NCT06263582 2025-08-19
Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
Clinical Trials
34 trialsNCT04017962 2025-08-11
A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT05251805 2025-06-08
The Safety and Feasibility of Costal Bone Marrow Aspiration During Thoracic Surgery
Universitair Ziekenhuis Brussel
Phase NA Terminated
NCT01437488 2025-05-04
Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy
Thomas Jefferson University
Phase 2 Completed
NCT04331067 2025-04-23
Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer
Washington University School of Medicine
Phase 1/2 Active not recruiting
NCT01186367 2025-02-10
Excite
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT02274662 2025-01-16
Expanded Access Protocol Thymus Transplantation
Sumitomo Pharma Switzerland GmbH
Phase 4 Completed
NCT04273893 2024-12-10
Lymphocyte Depletion and Change in Lymphocyte Functionality
University of Virginia
Phase NA Active not recruiting
NCT03956056 2024-07-17
Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Washington University School of Medicine
Phase 1 Terminated
NCT01904136 2024-01-24
Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT04040244 2023-10-11
Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis
Wake Forest University Health Sciences
Phase NA Terminated
NCT03860207 2023-09-13
Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers
Y-mAbs Therapeutics
Phase 1/2 Terminated
NCT02696759 2022-03-16
Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer
University of Arkansas
Phase NA Terminated
NCT03956615 2021-12-01
MUM
Universitair Ziekenhuis Brussel
Phase NA Completed
NCT03998189 2021-11-05
Metabolic and Microbial Profiling of Lung Cancer
Wake Forest University Health Sciences
Phase NA Terminated
NCT02485964 2021-10-07
A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer Vaccine
University of Arkansas
Phase NA Completed
NCT02907918 2021-09-29
PALTAN
Washington University School of Medicine
Phase 2 Terminated
NCT03665155 2021-07-30
First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT00927485 2020-12-16
Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
University of Puerto Rico
Phase NA Completed
NCT03355820 2020-11-19
A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study
GlaxoSmithKline
Phase 3 Completed
NCT00947115 2020-10-30
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects
GlaxoSmithKline
Phase 3 Completed
NCT00877877 2020-01-18
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.
GlaxoSmithKline
Phase 3 Completed
NCT00685750 2019-06-20
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
GlaxoSmithKline
Phase NA Terminated
NCT02410577 2019-03-19
89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00569309 2018-03-12
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT02241187 2017-09-27
Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00989586 2017-02-06
Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Ohio State University Comprehensive Cancer Center
Phase 1/2 Completed
NCT00518336 2016-12-09
Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil
GlaxoSmithKline
Phase 2 Completed
NCT00929526 2016-10-20
Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study
GlaxoSmithKline
Phase 3 Completed
NCT01048099 2016-01-29
Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer
SCRI Development Innovations, LLC
Phase NA Completed
NCT01521780 2015-11-02
Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215)
Merck Sharp & Dohme LLC
Phase 1 Terminated
NCT00930930 2015-05-07
Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
NCT01209520 2015-02-24
Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
University of Miami
Phase NA Completed
NCT01227018 2014-07-23
PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer
Vanderbilt-Ingram Cancer Center
Phase 2 Terminated